2025-01-282025-01-282011-052025-01-28Durán Lobato, M.M., Martín Banderas, L.,...,Almeida, A.J. (2025). Dataset of Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility. idUS (Depósito de Investigación de la Universidad de Sevilla). https://doi.org/10.12795/11441.https://hdl.handle.net/11441/167653This dataset corresponds to the article "Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility," published in Drug Development and Industrial Pharmacy. It includes experimental data on the development of CB13-loaded lipid nanoparticles (LNPs) prepared using the emulsification-solvent evaporation method. Data include particle size, polydispersity index (PDI), zeta potential, encapsulation efficiency, and stability studies. Biocompatibility was evaluated through cytotoxicity assays performed on NIH 3T3, HEK 293T, and Caco-2 cell lines.A single Excel file with each sheet collecting the data corresponding to a figure or table: -Figure 1: Data corresponding to manuscript Figure 1 on particle size zeta potential values of the formulations as a function on the different parameters assayed. -Figure 4: Data corresponding to manuscript Figure 4 on colloidal stability of the assayed formulations in biorelevant fluids. -Figure 5: Data corresponding to manuscript Figure 5 on the cytotoxic effect on NIH3T3 cells, HEK293T cells and Caco-2 cells of the different types of NPs assayed. -Figure A1: Data corresponding to manuscript Figure A1 on storage stability of the selected formulations.application/vnd.ms-excelengAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Lipid CarriersNanoparticle FormulationNeuropathic PainOral DeliveryPoorly Soluble DrugsTransportadores lipídicosFormulación de nanopartículasDolor neuropáticoLiberación oralFármacos de baja solubilidadinfo:eu-repo/semantics/datasetinfo:eu-repo/semantics/openAccess10.12795/11441/167653